The Cooper Health System

The Cooper Health System was paid $354.03M by Medicaid between Jan 2018 and Dec 2024, across 801 billing codes. Its largest line is 99285, emergency room visit (most serious) — 9.8% of everything it billed.

33Billing provider infoTHE COOPER HEALTH SYSTEM
CAMDEN, NJ 08103

33aNPI1568442309assigned 01/18/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$354.03M

24GClaims4,611,446

24DCodes billed801

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#2 of 93

Median peer was paid$30.60M

This provider vs. median12×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	559,312	$50.02M
2019	585,456	$52.94M
2020	480,593	$40.30M
2021	660,873	$48.99M
2022	817,103	$58.99M
2023	850,693	$58.34M
2024incomplete	657,416	$44.45M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	9.8%	72,387	65,511	$34.58M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	7.4%	89,970	80,196	$26.17M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.9%	81,460	71,283	$24.51M
J9271	Injection, pembrolizumab, 1 mg	5.0%	3,207	2,284	$17.83M
OP250		4.7%	316,512	193,044	$16.51M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	4.6%	13,858	13,123	$16.35M
G0378	Hospital observation service, per hour	4.4%	40,356	21,649	$15.57M
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	2.5%	45,720	35,960	$8.85M
96375	Therapeutic injection; each additional sequential IV push	2.2%	43,075	27,001	$7.82M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	2.0%	26,503	16,343	$6.93M
95810	Polysomnography; sleep staging with 4 or more additional parameters	1.9%	2,927	2,872	$6.65M
64483		1.7%	5,662	5,329	$5.84M

789 more codes

J2505	Injection, pegfilgrastim, 6 mg	1.5%	1,993	$5.33M
45380	Colonoscopy, flexible; with biopsy, single or multiple	1.5%	7,303	$5.14M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	1.3%	3,855	$4.54M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	7,533	$3.44M
59025	Fetal non-stress test	<1%	10,531	$3.40M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	3,679	$3.06M
A0427	Emergency ambulance ride, advanced life support	<1%	13,419	$2.91M
77386		<1%	13,954	$2.89M
OP710		<1%	32,213	$2.54M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	67,027	$2.51M
64493		<1%	2,110	$2.33M
77067	Screening mammography, bilateral, including computer-aided detection	<1%	23,151	$2.28M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	1,236	$2.25M
J9299	Injection, nivolumab, 1 mg	<1%	459	$2.24M
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	1,153	$2.14M
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	1,204	$2.13M
93458		<1%	905	$2.10M
62321		<1%	2,034	$2.09M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	19,406	$1.98M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	18,601	$1.97M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	4,651	$1.96M
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	1,005	$1.92M
96417		<1%	6,791	$1.90M
96415		<1%	8,117	$1.85M
OP272		<1%	36,249	$1.74M
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	1,533	$1.73M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	24,743	$1.72M
78815	Positron emission tomography (PET) for limited area imaging	<1%	2,612	$1.72M
96411		<1%	3,806	$1.70M
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	1,041	$1.67M
J0897	Injection, denosumab, 1 mg	<1%	1,659	$1.46M
62323		<1%	1,604	$1.42M
95816		<1%	3,730	$1.39M
64635		<1%	1,220	$1.35M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	3,616	$1.34M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	7,974	$1.31M
OP278		<1%	1,261	$1.30M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	29,841	$1.30M
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	4,321	$1.27M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	4,359	$1.24M
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	55,683	$1.18M
J9312	Injection, rituximab, 10 mg	<1%	278	$1.16M
43235		<1%	1,033	$1.12M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	23,054	$1.11M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	411	$1.08M
96361	Intravenous infusion, hydration; each additional hour	<1%	17,546	$1.08M
36415	Collection of venous blood by venipuncture	<1%	159,478	$1.04M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	10,443	$1.02M
64490		<1%	971	$1.02M
99213	Doctor's office visit, returning patient (routine)	<1%	12,309	$916K
94070		<1%	1,538	$908K
71046	Radiologic examination, chest; 2 views	<1%	48,478	$876K
C1776	Joint device (implantable)	<1%	912	$852K
74183		<1%	2,375	$849K
96416		<1%	3,639	$848K
36561		<1%	733	$837K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	723	$817K
41899	Unlisted procedure, dentoalveolar structures	<1%	939	$812K
95806		<1%	2,777	$806K
92557		<1%	3,914	$795K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	33,089	$766K
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	<1%	434	$754K
77412		<1%	10,476	$752K
70450	Computed tomography, head or brain; without contrast material	<1%	18,681	$739K
64721		<1%	742	$728K
72141		<1%	2,662	$724K
94060		<1%	2,590	$692K
19083		<1%	689	$690K
93971		<1%	4,044	$680K
77334		<1%	2,756	$676K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	7,626	$672K
94010		<1%	2,946	$669K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	30,775	$655K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	46,702	$652K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	412	$639K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	11,502	$637K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	11,544	$629K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	60,410	$617K
71250		<1%	5,343	$584K
93970		<1%	2,765	$576K
82948		<1%	57,506	$575K
94750		<1%	2,022	$568K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	118	$550K
77063	Screening digital breast tomosynthesis, bilateral	<1%	21,057	$538K
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	162	$516K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	9,158	$512K
92567		<1%	6,883	$508K
77066	Tomosynthesis, mammo	<1%	4,014	$507K
A0425	Ground mileage, per statute mile	<1%	58,459	$497K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,813	$493K
94729		<1%	6,207	$478K
73221		<1%	1,754	$471K
95950		<1%	271	$461K
31575		<1%	710	$456K
J0185	Injection, aprepitant, 1 mg	<1%	2,619	$455K
92579		<1%	2,109	$444K
76830	Ultrasound, transvaginal	<1%	7,044	$434K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,993	$426K
76770		<1%	5,956	$420K
77336		<1%	6,280	$417K
99214	Doctor's office visit, returning patient (more involved)	<1%	6,531	$407K
73030		<1%	10,008	$397K
J9310	Injection, rituximab, 100 mg	<1%	104	$394K
95708		<1%	1,788	$393K
49083		<1%	458	$382K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	4,228	$376K
92587		<1%	2,569	$375K
76536		<1%	5,042	$370K
72125	Computed tomography, cervical spine; without contrast material	<1%	9,230	$366K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	3,671	$365K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	35,642	$360K
80048	Basic metabolic panel (calcium, ionized)	<1%	124,411	$355K
J2704	Injection, propofol, 10 mg	<1%	83,770	$350K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	107,363	$348K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	10,063	$346K
94726		<1%	3,951	$331K
77300		<1%	1,783	$318K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	2,137	$312K
58300		<1%	233	$306K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	16,257	$306K
96523		<1%	3,976	$303K
73630		<1%	11,996	$302K
10005		<1%	326	$301K
70486		<1%	4,104	$301K
J2350	Injection, ocrelizumab, 1 mg	<1%	14	$301K
J1756	Injection, iron sucrose, 1 mg	<1%	7,032	$298K
76642		<1%	6,300	$298K
77065	Tomosynthesis, mammo	<1%	4,068	$297K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	5,889	$296K
73130		<1%	8,910	$293K
C1889	Implantable/insertable device, not otherwise classified	<1%	2,516	$292K
C1760	Closure device, vascular (implantable/insertable)	<1%	651	$285K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	19,703	$279K
OP259		<1%	86,333	$275K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	802	$271K
74178		<1%	1,181	$267K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	14,578	$264K
71271		<1%	1,633	$263K
70496		<1%	3,033	$255K
85027		<1%	70,566	$239K
73564		<1%	5,896	$238K
72110		<1%	5,233	$233K
80053	Comprehensive metabolic panel	<1%	36,722	$232K
76641		<1%	2,852	$227K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	19,692	$225K
77301		<1%	427	$224K
86900		<1%	26,188	$222K
81025		<1%	24,632	$221K
70498		<1%	3,112	$213K
84443	Thyroid stimulating hormone (TSH)	<1%	24,676	$212K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	61,449	$208K
88341		<1%	4,505	$207K
96401		<1%	2,144	$206K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	4,807	$205K
70491		<1%	1,783	$202K
C1769	Guide wire	<1%	8,305	$198K
96402		<1%	3,152	$196K
73610		<1%	7,899	$194K
A9585	Injection, gadobutrol, 0.1 ml	<1%	16,754	$193K
27096		<1%	158	$189K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	475	$185K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	10,410	$184K
73110		<1%	5,464	$184K
99215	Doctor's office visit, returning patient (complex)	<1%	2,164	$180K
20553		<1%	190	$175K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,941	$173K
20680		<1%	122	$172K
88307		<1%	3,374	$170K
77049		<1%	478	$168K
86850		<1%	25,302	$167K
J7030	Infusion, normal saline solution , 1000 cc	<1%	25,455	$163K
73560		<1%	8,379	$161K
88342		<1%	8,983	$157K
74240		<1%	1,384	$156K
92588		<1%	847	$154K
87536		<1%	3,172	$154K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	3,860	$151K
92523		<1%	2,192	$148K
OP681		<1%	1,061	$145K
52000		<1%	174	$144K
90651		<1%	1,232	$142K
72158		<1%	475	$136K
C1729	Catheter, drainage	<1%	1,586	$136K
72100		<1%	4,100	$132K
36430		<1%	3,101	$132K
80061	Lipid panel	<1%	20,805	$131K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	340	$129K
77290		<1%	605	$127K
95811		<1%	79	$126K
10022		<1%	137	$126K
20610		<1%	224	$124K
52005		<1%	112	$122K
72050		<1%	2,563	$119K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	2,020	$118K
72156		<1%	392	$118K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	25,861	$118K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	48,781	$117K
71045	Radiologic examination, chest; single view	<1%	9,097	$115K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	10,108	$114K
73080		<1%	3,274	$113K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	4,469	$113K
78306		<1%	1,085	$112K
97161		<1%	8,166	$111K
96376		<1%	14,933	$111K
A4648	Tissue marker, implantable, any type, each	<1%	1,201	$110K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	8,396	$109K
73700		<1%	1,042	$108K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	2,840	$107K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,633	$107K
93041		<1%	13,600	$105K
92610		<1%	1,183	$105K
88142		<1%	3,471	$102K
72040		<1%	2,584	$101K
64484		<1%	2,370	$100K
73502		<1%	5,041	$99K
88185		<1%	1,174	$99K
74420		<1%	1,128	$99K
84703		<1%	26,226	$98K
47562		<1%	66	$95K
J9070	Cyclophosphamide, 100 mg	<1%	285	$95K
64494		<1%	1,304	$95K
36000		<1%	14,704	$94K
92526		<1%	2,053	$93K
90715		<1%	7,574	$92K
73590		<1%	4,253	$92K
77295		<1%	144	$91K
72197		<1%	229	$91K
72070		<1%	2,419	$91K
86360		<1%	3,085	$91K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	38,897	$90K
76870		<1%	2,051	$89K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	2,871	$88K
J9190	Injection, fluorouracil, 500 mg	<1%	5,041	$88K
91020		<1%	79	$88K
OP252		<1%	19,338	$87K
74246		<1%	995	$87K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	117	$86K
83036	Hemoglobin; glycosylated (A1C)	<1%	22,764	$86K
J1453	Injection, fosaprepitant, 1 mg	<1%	402	$83K
J0690	Injection, cefazolin sodium, 500 mg	<1%	18,690	$82K
81001		<1%	50,461	$82K
88360		<1%	1,853	$81K
73562		<1%	2,036	$80K
96367		<1%	4,067	$79K
10060		<1%	1,054	$79K
86901		<1%	26,659	$78K
80076		<1%	40,966	$78K
A0436	Rotary wing air mileage, per statute mile	<1%	432	$78K
92611		<1%	237	$77K
85610		<1%	34,898	$77K
73090		<1%	3,020	$77K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	42,245	$76K
J9045	Injection, carboplatin, 50 mg	<1%	2,750	$75K
78264		<1%	599	$74K
76775		<1%	1,212	$74K
83735		<1%	42,664	$74K
58558		<1%	77	$72K
73120		<1%	2,073	$72K
20552		<1%	68	$70K
86803		<1%	5,215	$70K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	60	$69K
85007		<1%	27,705	$69K
J3490	Unclassified drugs	<1%	44,697	$69K
86359		<1%	3,091	$68K
74174		<1%	948	$68K
96368		<1%	3,616	$67K
77338		<1%	433	$66K
76818		<1%	797	$65K
74022		<1%	2,959	$64K
86480		<1%	1,848	$63K
84484		<1%	23,577	$63K
76937		<1%	3,132	$62K
45381		<1%	212	$61K
87390		<1%	7,490	$61K
C1781	Mesh (implantable)	<1%	278	$61K
77080		<1%	1,817	$59K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	5,824	$59K
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	<1%	54	$59K
93308		<1%	2,529	$58K
J1815	Injection, insulin, per 5 units	<1%	5,225	$58K
72146		<1%	241	$58K
87088		<1%	21,716	$54K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,798	$53K
J9267	Injection, paclitaxel, 1 mg	<1%	2,188	$53K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	1,414	$53K
74018		<1%	2,114	$52K
76882		<1%	2,021	$51K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	43,965	$50K
82728		<1%	7,214	$49K
58100		<1%	65	$49K
70544		<1%	233	$49K
58301		<1%	40	$48K
74241		<1%	454	$48K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	567	$48K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	2,131	$48K
27447		<1%	65	$47K
J3370	Injection, vancomycin hcl, 500 mg	<1%	5,518	$47K
73552		<1%	2,679	$47K
88172		<1%	1,304	$46K
A0998	Ambulance response and treatment, no transport	<1%	519	$46K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	13,847	$46K
J9171	Injection, docetaxel, 1 mg	<1%	520	$45K
0011A		<1%	1,419	$44K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	6,420	$44K
58661		<1%	48	$44K
J0491	Injection, anifrolumab-fnia, 1 mg	<1%	15	$43K
OP270		<1%	3,035	$43K
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	4,109	$42K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	14,970	$41K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	10,186	$41K
73523		<1%	854	$41K
J9395	Injection, fulvestrant, 25 mg	<1%	110	$40K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	869	$39K
73060		<1%	1,637	$39K
88304		<1%	4,773	$39K
64636		<1%	456	$39K
86702		<1%	5,560	$38K
OP258		<1%	28,057	$38K
74230		<1%	868	$38K
76942		<1%	653	$38K
83880		<1%	6,667	$37K
0001A		<1%	1,128	$37K
74019		<1%	1,223	$37K
87081		<1%	5,292	$37K
73600		<1%	1,235	$37K
84100		<1%	21,910	$37K
J9041	Injection, bortezomib, 0.1 mg	<1%	46	$36K
72080		<1%	1,150	$36K
86701		<1%	5,532	$36K
95886		<1%	440	$36K
72157		<1%	115	$36K
97165		<1%	2,920	$36K
85730		<1%	15,330	$36K
75574		<1%	158	$35K
97166		<1%	712	$35K
J1644	Injection, heparin sodium, per 1000 units	<1%	7,029	$34K
78816		<1%	40	$33K
88313		<1%	1,347	$33K
86923		<1%	2,726	$33K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,771	$33K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	283	$32K
76377		<1%	1,234	$32K
81003		<1%	16,734	$32K
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	<1%	620	$32K
76981		<1%	519	$32K
83021		<1%	1,908	$31K
77470		<1%	90	$31K
82607		<1%	5,391	$30K
0012A		<1%	900	$30K
95800		<1%	141	$30K
0002A		<1%	826	$30K
OP251		<1%	4,424	$30K
72052		<1%	642	$30K
83605		<1%	10,832	$30K
83970		<1%	1,800	$29K
J9206	Injection, irinotecan, 20 mg	<1%	934	$29K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	4,902	$28K
87340		<1%	3,511	$28K
64633		<1%	29	$28K
51701		<1%	322	$28K
83690		<1%	21,760	$27K
72131		<1%	411	$27K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	18,344	$27K
72114		<1%	684	$27K
97164		<1%	1,357	$27K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	7,445	$27K
C1892	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away	<1%	619	$27K
90686		<1%	3,465	$27K
12011		<1%	499	$26K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,718	$25K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	552	$24K
87077		<1%	6,099	$24K
95819		<1%	55	$24K
83550		<1%	6,394	$23K
84702		<1%	5,729	$23K
42830		<1%	14	$23K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	9,258	$23K
73522		<1%	657	$23K
87641		<1%	2,757	$23K
87070		<1%	3,908	$23K
45330		<1%	26	$22K
88173		<1%	2,231	$22K
72120		<1%	675	$22K
73200		<1%	184	$22K
0031A		<1%	797	$22K
C1788	Port, indwelling (implantable)	<1%	461	$22K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	948	$22K
99204	Doctor's office visit, new patient (more involved)	<1%	270	$21K
96377		<1%	1,320	$21K
87186		<1%	5,776	$21K
87640		<1%	2,631	$21K
0064A		<1%	702	$21K
90733		<1%	337	$21K
62322		<1%	30	$21K
J7050	Infusion, normal saline solution, 250 cc	<1%	6,646	$21K
84439		<1%	4,745	$20K
72170		<1%	1,515	$20K
77001		<1%	705	$20K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	98	$20K
0004A		<1%	691	$20K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	989	$20K
99152		<1%	2,970	$19K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	26,344	$19K
84153		<1%	2,361	$19K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	14,896	$19K
77059		<1%	39	$19K
99153	Mod sedat endo service >5yrs	<1%	2,654	$19K
87522	Neg quan hep c or qual rna	<1%	1,521	$19K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	2,102	$18K
J1170	Injection, hydromorphone, up to 4 mg	<1%	16,065	$18K
80329		<1%	3,612	$18K
80074		<1%	1,534	$18K
88184		<1%	876	$17K
76098		<1%	317	$17K
36590		<1%	13	$17K
77061		<1%	1,577	$17K
73100		<1%	482	$17K
82784		<1%	1,785	$17K
A0433	Advanced life support, level 2 (als 2)	<1%	69	$17K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	38	$17K
86703		<1%	2,394	$16K
86706		<1%	2,322	$16K
45331		<1%	12	$16K
70360		<1%	725	$16K
64450		<1%	26	$16K
73000		<1%	447	$15K
93017		<1%	66	$15K
81401		<1%	143	$15K
87040		<1%	4,525	$15K
64491		<1%	479	$15K
58571		<1%	45	$15K
96409		<1%	54	$15K
83540		<1%	5,859	$15K
82746		<1%	2,414	$14K
26055		<1%	13	$14K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	2,089	$14K
97802		<1%	1,518	$14K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	1,191	$14K
82570		<1%	9,587	$14K
99203	Doctor's office visit, new patient (routine)	<1%	177	$14K
86140		<1%	9,085	$13K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,386	$13K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	8,973	$13K
G0379	Direct admission of patient for hospital observation care	<1%	155	$13K
29515		<1%	475	$13K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	120	$13K
83520		<1%	876	$13K
82043		<1%	6,638	$12K
C1726	Catheter, balloon dilatation, non-vascular	<1%	604	$12K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,748	$12K
29125		<1%	325	$12K
43251		<1%	18	$12K
74220		<1%	92	$12K
82330		<1%	2,485	$12K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,856	$12K
97162		<1%	399	$12K
86592		<1%	8,583	$12K
92609		<1%	199	$12K
12002		<1%	267	$11K
73070		<1%	696	$11K
72082		<1%	238	$11K
38222		<1%	14	$11K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	9,442	$11K
88112		<1%	1,335	$11K
86762		<1%	1,556	$11K
12001		<1%	480	$11K
77417		<1%	676	$10K
94618		<1%	396	$10K
70487		<1%	217	$10K
86704		<1%	1,411	$10K
80320		<1%	5,664	$10K
74221		<1%	207	$10K
19301		<1%	18	$10K
73620		<1%	468	$10K
J3489	Injection, zoledronic acid, 1 mg	<1%	228	$10K
81000		<1%	5,644	$10K
70480		<1%	79	$10K
86235		<1%	338	$10K
83655		<1%	958	$10K
85018		<1%	2,498	$10K
87210		<1%	4,908	$10K
87147		<1%	3,623	$9K
83883		<1%	326	$9K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	145	$9K
77002		<1%	208	$9K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,441	$9K
86922		<1%	273	$9K
OP720		<1%	131	$9K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	37	$9K
84403		<1%	484	$9K
86038		<1%	1,653	$9K
82550		<1%	4,972	$9K
87205		<1%	3,371	$9K
88302		<1%	629	$9K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	4,827	$9K
82803		<1%	1,647	$9K
85097		<1%	69	$9K
90677		<1%	63	$8K
87075		<1%	2,755	$8K
85652		<1%	8,346	$8K
0124A		<1%	345	$8K
84132		<1%	1,941	$8K
88300		<1%	1,199	$8K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	6,000	$8K
J2997	Injection, alteplase recombinant, 1 mg	<1%	27	$8K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	503	$8K
93923		<1%	29	$8K
86160		<1%	1,397	$8K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	298	$8K
76801		<1%	315	$8K
97535	Self-care/home management training, each 15 minutes	<1%	1,172	$7K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	462	$7K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	43	$7K
77072		<1%	159	$7K
73718		<1%	27	$7K
J2060	Injection, lorazepam, 2 mg	<1%	2,606	$7K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	6,884	$7K
75561		<1%	14	$7K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,766	$7K
Q0114	Fern test	<1%	1,515	$7K
84295		<1%	1,618	$7K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	573	$7K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	457	$7K
93975		<1%	26	$7K
0134A		<1%	300	$7K
93312		<1%	12	$7K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,646	$7K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	86	$7K
0072A		<1%	188	$7K
90832	Psychotherapy session, about 30 minutes	<1%	166	$6K
80179		<1%	1,881	$6K
19081		<1%	14	$6K
88311		<1%	1,109	$6K
0054A		<1%	225	$6K
80069		<1%	2,358	$6K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	5,906	$6K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	641	$6K
97116		<1%	2,258	$6K
82248		<1%	1,581	$6K
85045		<1%	2,528	$6K
82247		<1%	1,452	$6K
0071A		<1%	147	$6K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	655	$5K
G0390	Trauma response team associated with hospital critical care service	<1%	43	$5K
86870		<1%	216	$5K
G0008	Administration of influenza virus vaccine	<1%	459	$5K
83615		<1%	2,535	$5K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	13	$5K
86905		<1%	737	$5K
38900		<1%	56	$5K
J8501	Aprepitant, oral, 5 mg	<1%	528	$5K
0051A		<1%	144	$5K
59200		<1%	13	$5K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	925	$5K
86255		<1%	1,087	$5K
81329		<1%	48	$5K
84311		<1%	770	$5K
70543		<1%	15	$4K
82105		<1%	482	$4K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	1,257	$4K
84146		<1%	309	$4K
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	227	$4K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	1,295	$4K
29888		<1%	15	$4K
84156		<1%	2,097	$4K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	724	$4K
C1758	Catheter, ureteral	<1%	1,289	$4K
85379		<1%	3,834	$4K
77333		<1%	58	$4K
77387		<1%	242	$4K
83516		<1%	630	$4K
76000		<1%	106	$4K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	358	$4K
77014		<1%	69	$4K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,638	$3K
C2625	Stent, non-coronary, temporary, with delivery system	<1%	49	$3K
77012		<1%	40	$3K
87324		<1%	111	$3K
90834	Psychotherapy session, about 45 minutes	<1%	111	$3K
82272		<1%	620	$3K
97010		<1%	494	$3K
88312		<1%	367	$3K
82805		<1%	1,096	$3K
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	<1%	123	$3K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	37	$3K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	31	$3K
82533		<1%	467	$3K
92553		<1%	42	$3K
93325		<1%	12	$3K
80164		<1%	458	$3K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	1,777	$3K
86769		<1%	367	$3K
87529		<1%	360	$3K
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	2,432	$3K
0052A		<1%	87	$3K
84550		<1%	1,877	$3K
86708		<1%	281	$3K
64447		<1%	22	$3K
83986		<1%	827	$3K
88331		<1%	134	$3K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	6,869	$2K
94660		<1%	107	$2K
84481		<1%	444	$2K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	16	$2K
90732		<1%	208	$2K
87206		<1%	459	$2K
82977		<1%	833	$2K
83010		<1%	271	$2K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	32	$2K
87102		<1%	408	$2K
91320		<1%	32	$2K
90658		<1%	182	$2K
84165		<1%	535	$2K
72192		<1%	12	$2K
99205	Prolong outpt/office vis	<1%	14	$2K
82310		<1%	1,750	$2K
93880		<1%	12	$2K
82010		<1%	1,411	$2K
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	282	$2K
82565		<1%	876	$2K
85384		<1%	236	$2K
90792	Psychiatric diagnostic evaluation with medical services	<1%	100	$2K
84402		<1%	101	$2K
J1630	Injection, haloperidol, up to 5 mg	<1%	2,964	$2K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,728	$2K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	20	$2K
82951		<1%	370	$2K
86618		<1%	186	$2K
0399T		<1%	13	$2K
90472	Immunization administration, each additional vaccine (list separately)	<1%	341	$2K
92552		<1%	12	$2K
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	122	$2K
J1940	Injection, furosemide, up to 20 mg	<1%	1,273	$2K
84425		<1%	145	$2K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	57	$2K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	109	$1K
92524		<1%	25	$1K
86334		<1%	231	$1K
76376		<1%	23	$1K
87807		<1%	138	$1K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	4,012	$1K
87086	Culture, bacterial; quantitative colony count, urine	<1%	752	$1K
OP271		<1%	3,103	$1K
82378		<1%	173	$1K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	27	$1K
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	2,624	$1K
36416		<1%	278	$1K
82270		<1%	173	$1K
38792		<1%	20	$1K
0034A		<1%	57	$1K
C9113	Injection, pantoprazole sodium, per vial	<1%	2,556	$1K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	513	$1K
87045		<1%	200	$1K
64495		<1%	26	$997.43
99195		<1%	16	$993.85
84145		<1%	380	$978.77
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	<1%	91	$970.66
86430		<1%	841	$918.71
72190		<1%	25	$894.53
89051		<1%	452	$888.57
76604		<1%	29	$863.13
82040		<1%	1,050	$856.19
90739		<1%	26	$843.33
90670		<1%	38	$841.22
70355		<1%	110	$823.15
99385		<1%	12	$806.82
83001		<1%	79	$799.40
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	5,672	$783.37
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	19	$759.04
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	370	$758.50
83521		<1%	196	$751.91
90480		<1%	32	$720.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	1,040	$702.89
76885		<1%	12	$694.53
86304		<1%	102	$693.17
87118		<1%	78	$657.54
0003A		<1%	23	$657.08
J1953	Injection, levetiracetam, 10 mg	<1%	219	$619.20
82945		<1%	104	$595.57
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	530	$574.85
C1782	Morcellator	<1%	41	$541.65
93888		<1%	12	$490.02
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,614	$476.98
87899		<1%	111	$460.18
71101		<1%	12	$451.36
83921		<1%	44	$440.42
12013		<1%	16	$422.82
73140		<1%	26	$409.19
83993		<1%	27	$408.98
J2785	Injection, regadenoson, 0.1 mg	<1%	13	$408.78
71100		<1%	27	$393.60
36593		<1%	12	$378.52
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	58	$373.58
82140		<1%	172	$373.18
88333		<1%	62	$372.43
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,393	$359.65
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	497	$352.21
87209		<1%	53	$327.65
S0190	Mifepristone, oral, 200 mg	<1%	31	$320.60
82150		<1%	136	$313.50
90791	Psychiatric diagnostic evaluation	<1%	26	$303.16
87517		<1%	12	$273.29
C2617	Stent, non-coronary, temporary, without delivery system	<1%	13	$272.85
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,580	$263.26
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	198	$262.95
J9370	Vincristine sulfate, 1 mg	<1%	35	$262.29
83002		<1%	30	$256.51
J0703	Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg	<1%	112	$248.18
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	446	$244.55
87563		<1%	102	$224.45
84157		<1%	158	$222.39
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	450	$219.11
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	30	$214.64
87338		<1%	25	$212.85
90632		<1%	12	$208.09
86885		<1%	19	$187.67
86705		<1%	15	$178.40
87046		<1%	188	$172.54
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	29	$160.46
87116		<1%	108	$149.86
80202		<1%	23	$144.00
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	298	$142.29
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	900	$136.51
85014		<1%	231	$133.36
82172		<1%	13	$129.42
86787		<1%	12	$123.48
87177		<1%	53	$111.75
29505		<1%	26	$104.40
J2150	Injection, mannitol, 25% in 50 ml	<1%	58	$99.76
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	254	$98.95
J1171	Injection, hydromorphone, 0.1 mg	<1%	355	$98.56
J2470	Injection, pantoprazole sodium, 40 mg	<1%	183	$90.02
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	686	$86.43
86376		<1%	13	$83.44
84460		<1%	57	$80.86
83519		<1%	13	$80.72
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	121	$78.18
85041		<1%	123	$74.14
J3250	Injection, trimethobenzamide hcl, up to 200 mg	<1%	20	$72.08
82274		<1%	28	$71.00
80177		<1%	31	$65.72
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	182	$64.85
86880		<1%	25	$61.50
84300		<1%	29	$58.43
89060		<1%	14	$55.66
90656		<1%	19	$55.39
82657		<1%	23	$51.60
86593		<1%	17	$51.38
J7510	Prednisolone oral, per 5 mg	<1%	495	$48.95
90756		<1%	16	$48.60
92522		<1%	12	$48.17
J1836	Injection, metronidazole, 10 mg	<1%	206	$43.03
J1956	Injection, levofloxacin, 250 mg	<1%	44	$37.62
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	106	$37.19
J3411	Injection, thiamine hcl, 100 mg	<1%	120	$31.05
82435		<1%	341	$27.36
82947		<1%	200	$27.10
81002		<1%	35	$26.75
A4649	Surgical supply; miscellaneous	<1%	22	$25.81
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	<1%	461	$18.47
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	32	$16.00
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	232	$15.14
89050		<1%	37	$9.62
82962		<1%	18	$7.80
86308		<1%	12	$7.60
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	12	$7.47
91312		<1%	367	$4.00
91305		<1%	582	$2.00
91303		<1%	817	$1.00
91307		<1%	328	$0.01
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	0%	14	$0.00
90611		0%	96	$0.00
D9230	Inhalation of nitrous oxide / analgesia, anxiolysis	0%	16	$0.00
64634		0%	15	$0.00
91313		0%	299	$0.00
J0585	Injection, onabotulinumtoxina, 1 unit	0%	35	$0.00
94664		0%	64	$0.00
91300		0%	2,644	$0.00
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	0%	20	$0.00
J0184	Injection, amisulpride, 1 mg	0%	12	$0.00
38525		0%	21	$0.00
91306		0%	687	$0.00
91301		0%	2,337	$0.00
Q0222	Injection, bebtelovimab, 175 mg	0%	44	$0.00
90935	Hemodialysis procedure with single evaluation by a physician	0%	21	$0.00
Q9992	Injection, buprenorphine extended-release (sublocade), greater than 100 mg	0%	15	$0.00
OP637		0%	345	$0.00
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	0%	16	$0.00
Q0247	Injection, sotrovimab, 500 mg	0%	29	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialREILLY, BRIAN (CFO)

Same official

Other billing entities under REILLY, BRIAN

Full network →

Provider	Location	Paid
Family Care Chiropractic Center, Brian D.Reilly D.C.,P.A.	Hot Springs, AR	$56K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.